BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26323425)

  • 1. Nanotechnology in Drug Delivery: Safety and Toxicity Issues.
    Jain K; Mehra NK; Jain NK
    Curr Pharm Des; 2015; 21(29):4252-61. PubMed ID: 26323425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel applications of nanotechnology in medicine.
    Surendiran A; Sandhiya S; Pradhan SC; Adithan C
    Indian J Med Res; 2009 Dec; 130(6):689-701. PubMed ID: 20090129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterials for biomedical applications.
    Cao YC
    Nanomedicine (Lond); 2008 Aug; 3(4):467-9. PubMed ID: 18694308
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanomedicines: addressing the scientific and regulatory gap.
    Tinkle S; McNeil SE; Mühlebach S; Bawa R; Borchard G; Barenholz YC; Tamarkin L; Desai N
    Ann N Y Acad Sci; 2014 Apr; 1313():35-56. PubMed ID: 24673240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology enables superior medical therapies.
    Foldvari M; Elsabahy M
    Curr Drug Deliv; 2011 May; 8(3):225-6. PubMed ID: 21291383
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulating Nanomedicine for Cancer Therapy.
    Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
    Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated Regulatory Considerations for Nanomedicines.
    Subin TS; Vijayan V; Kumar KJR
    Pharm Nanotechnol; 2017; 5(3):180-191. PubMed ID: 28641516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology and human health: risks and benefits.
    Cattaneo AG; Gornati R; Sabbioni E; Chiriva-Internati M; Cobos E; Jenkins MR; Bernardini G
    J Appl Toxicol; 2010 Nov; 30(8):730-44. PubMed ID: 21117037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine: a new frontier in cancer therapeutics.
    Lee PY; Wong KK
    Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swiss National Research Programme "Opportunities and Risks of Nanomaterials" (NRP 64): key findings.
    Aebi U; Gehr P
    J Nanobiotechnology; 2017 Jun; 15(1):47. PubMed ID: 28645282
    [No Abstract]   [Full Text] [Related]  

  • 18. Tunable resistive pulse sensing: potential applications in nanomedicine.
    Sivakumaran M; Platt M
    Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.